Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

NCT07202039 is registered in ClinicalTrials.gov with Prisma Health-Upstate as lead sponsor.

NCT NCT07202039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07202039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
Lead sponsor
Prisma Health-Upstate
Phase
Not applicable
Overall status
Recruiting
Start date
April 29, 2026
Completion date
June 29, 2029
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sweet non-cooling ec, sweet-cooling ec, tobacco-flavored ec